Targeting Chemokines and Chemokine Receptors in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Sarah Dhaiban, Mena Al-Ani, Noha Mousaad Elemam, Azzam A Maghazachi College of Medicine and Immuno-Oncology Group, Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab EmiratesCorrespondence: Azzam A MaghazachiDepartment of Clinical Sciences, College of Medicine, Unive...
Guardado en:
Autores principales: | Dhaiban S, Al-Ani M, Elemam NM, Maghazachi AA |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9bfd1473d8b24391aa84c3248f0b7ec4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ELR positive CXCL chemokines are highly expressed in an animal model of ulcerative colitis
por: Boshagh MA, et al.
Publicado: (2019) -
Therapeutic Effect of C-C Chemokine Receptor Type 1 (CCR1) Antagonist BX471 on Allergic Rhinitis
por: Feng S, et al.
Publicado: (2020) -
EXPRESSION OF mRNAS FOR CHEMOKINES AND CHEMOKINE RECEPTORS IN THE SKIN FROM PATIENTS WITH PSORIASIS
por: A. S. Beltiukova, et al.
Publicado: (2014) -
Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
por: Ghareghani Majid, et al.
Publicado: (2021) -
GENE POLYMORPHISM ANALYSIS OF CHEMOKINES, CHEMOKINE RECEPTORS, ACUTE PHASE PROTEINS, AND CD14 IN FEMALE OBESITY DEVELOPMENT
por: O. V. Kochetova, et al.
Publicado: (2018)